Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chuck Harrell

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Cancers|March 11, 2023
Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXsDavid C Boyd, Emily K Zboril, Amy L Olex, et al.
Scientific Reports|April 3, 2023
Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Scientific Reports|December 17, 2024
Author Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Scientific Reports|May 10, 2023
Publisher Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Scientific Reports|December 9, 2022
Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancerNarmeen S Rashid, David C Boyd, Amy L Olex, et al.
Nature|April 10, 2015
A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasisElvin Wagenblast, Mar Soto, Sara Gutiérrez-Ángel, et al.
Nature Communications|December 22, 2015
The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3pChristina G Towers, Anna L Guarnieri, Doug S Micalizzi, et al.
Clinical and Translational Medicine|October 17, 2024
Single-cell transcriptional atlas of human breast cancers and model systemsJulia E Altman, Amy L Olex, Emily K Zboril, et al.
Molecular Cancer Therapeutics|November 24, 2021
Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast CancerJames D Hampton, Erica J Peterson, Samantha J Katner, et al.
PNAS Nexus|January 30, 2023
Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer modelsSheeba Jacob, Tia H Turner, Jinyang Cai, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cancers|March 11, 2023
Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXsDavid C Boyd, Emily K Zboril, Amy L Olex, et al.
Scientific Reports|April 3, 2023
Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Scientific Reports|December 17, 2024
Author Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Scientific Reports|May 10, 2023
Publisher Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograftMikhail G Dozmorov, Maggie A Marshall, Narmeen S Rashid, et al.
Scientific Reports|December 9, 2022
Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancerNarmeen S Rashid, David C Boyd, Amy L Olex, et al.
Nature|April 10, 2015
A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasisElvin Wagenblast, Mar Soto, Sara Gutiérrez-Ángel, et al.
Nature Communications|December 22, 2015
The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3pChristina G Towers, Anna L Guarnieri, Doug S Micalizzi, et al.
Clinical and Translational Medicine|October 17, 2024
Single-cell transcriptional atlas of human breast cancers and model systemsJulia E Altman, Amy L Olex, Emily K Zboril, et al.
Molecular Cancer Therapeutics|November 24, 2021
Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast CancerJames D Hampton, Erica J Peterson, Samantha J Katner, et al.
PNAS Nexus|January 30, 2023
Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer modelsSheeba Jacob, Tia H Turner, Jinyang Cai, et al.
Pageof 8